Articles by Andrew Vassil, MD
Hypofractionated and Stereotactic Body Radiotherapy in Prostate Cancer
ByChirag Shah, MD,Kevin Stephans, MD,Aditya Juloori, MD,Andrew Vassil, MD,Constantine Mantz, MD,Alvaro Martinez, MD,Frank Vicini, MD,Eduardo Fernandez, MD,Rahul D. Tendulkar, MD,Steven E. Finkelstein, MD Despite limited data comparing stereotactic body radiation therapy to standard or hypofractionated radiotherapy with regards to long-term clinical outcomes and toxicity profiles, the data are promising and appropriately selected patients can be offered such an approach off-protocol.
